Novartis has revised its mid-term performance outlook ahead of its Meet Novartis Management event for financial stakeholders in London. The initial guidance of +5% sales CAGR from 2023 to 2028 has been adjusted to +6%, fueled by the current momentum […]
**BioLineRx Ltd., a biopharmaceutical firm focused on transformative treatments for cancer and uncommon medical conditions, and Ayrmid Ltd., the umbrella organization of Gamida Cell Ltd., revealed their new licensing arrangement on November 20, 2024. The agreement is set to advance
BioLineRx and Ayrmid Forge Partnership to Market Aphexda via Gamida Cell Read More »
A groundbreaking study has shed light on how a seldom-seen genetic anomaly can disrupt brain cell interactions, offering vital understanding of its role in a major neurological condition called developmental and epileptic encephalopathy (DEE). Insights from the research show that
Rare Genetic Anomaly Identified as a Contributor to Intense Neurological Disorder Read More »
Jazz Pharmaceuticals plc has announced that the US Food and Drug Administration (FDA) has expedited the approval of Ziihera (zanidatamab-hrii) 50mg/mL for intravenous administration. This approval targets adults with previously treated, unresectable, or metastatic HER2-positive (IHC 3+) biliary tract cancer
The World Health Organization (WHO) has approved Emergency Use Listing (EUL) for the LC16m8 mpox vaccine. This marks it as the second vaccine endorsement by WHO after the August 14, 2024, declaration of an mpox international public health emergency by
Emergency Use Approval Granted to LC16m8 mpox Vaccine by WHO Read More »
Syngene has commenced a bioequivalence study on an injectable intended for type-2 diabetes and weight regulation, following the approach of a global pharmaceutical firm seeking to partner for outsourced human pharmacological studies of semaglutide. The reference medication, Ozempic, is used
In an effort to enhance the clarity and efficiency of the approval process for manufacturing licenses in medical device sectors, the central government is planning revisions to the Medical Device Rules (MDR), 2017. These changes will incorporate specific timelines related
The Indian Council of Medical Research (ICMR) has launched a call for proposals as part of its Centre for Advanced Research (CAR) initiative, aimed at supporting clinical studies focused on novel medical device and diagnostic technologies developed through the ICMR-DHR-Centre
Transformations in digital technology have revolutionized biological research, offering profound insights into the complexities of living systems. According to Kiran Mazumdar-Shaw, chairperson of the Biocon Group and the Association of Biotechnology Led Enterprises (ABLE), bioengineering represents the next horizon in
Kiran Mazumdar Shaw Envisions Bioengineering as the Next Wave of Technological Progress Read More »
Centering on the Updated Schedule M within the Drugs and Cosmetics Act of 1940, the Central Drug Research Institute (CDRI) located in Lucknow, Uttar Pradesh, will conduct an industry conclave featuring panel discussions on November 23. Invitations are extended to